Chikara Ogimi, Hu Xie, Alpana Waghmare, Keith R Jerome, Wendy M Leisenring, Masumi Ueda Oshima, Paul A Carpenter, Janet A Englund, Michael Boeckh
{"title":"Correction: Novel factors to predict respiratory viral disease progression in allogeneic hematopoietic cell transplant recipients.","authors":"Chikara Ogimi, Hu Xie, Alpana Waghmare, Keith R Jerome, Wendy M Leisenring, Masumi Ueda Oshima, Paul A Carpenter, Janet A Englund, Michael Boeckh","doi":"10.1038/s41409-024-02418-9","DOIUrl":"https://doi.org/10.1038/s41409-024-02418-9","url":null,"abstract":"","PeriodicalId":9126,"journal":{"name":"Bone Marrow Transplantation","volume":" ","pages":""},"PeriodicalIF":4.5,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142406073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Stefania Bramanti, Daniele Mannina, Annalisa Chiappella, Beatrice Casadei, Chiara De Philippis, Laura Giordano, Pierina Navarria, Pietro Mancosu, Daniela Taurino, Marta Scorsetti, Carmelo Carlo-Stella, Pierluigi Zinzani, Armando Santoro, Paolo Corradini
{"title":"Role of bridging RT in relapsed/refractory diffuse large B-cell lymphoma undergoing CAR-T therapy: a multicenter study.","authors":"Stefania Bramanti, Daniele Mannina, Annalisa Chiappella, Beatrice Casadei, Chiara De Philippis, Laura Giordano, Pierina Navarria, Pietro Mancosu, Daniela Taurino, Marta Scorsetti, Carmelo Carlo-Stella, Pierluigi Zinzani, Armando Santoro, Paolo Corradini","doi":"10.1038/s41409-024-02427-8","DOIUrl":"https://doi.org/10.1038/s41409-024-02427-8","url":null,"abstract":"<p><p>The optimization of bridging regimen before chimeric antigen receptor (CAR)-T cell therapy in diffuse large B-cell lymphoma (DLBCL) may impact CAR-T efficacy and outcome. This retrospective study evaluates CAR-T outcome after bridging with radiotherapy (RT) and other bridging strategies. Among 148 patients with relapsed/refractory DLBCL who underwent leukapheresis for CAR-T manufacturing, 31 received RT-bridging, 84 chemotherapy (CT), 33 no-bridging or steroid-only. CAR-T cell were infused in 96.8% of RT-group, 89.2% of CT-group and 78.8% of no-bridge-group (p = 0.079). Response to bridging was generally poor, but patients receiving RT had a significant reduction in LDH levels between pre- and post-bridging (p = 0.05). The one-year PFS was 51.2% in the RT-group, 28.2% in the CT-group, and 47.6% in the no-bridge-group (p = 0.044, CT-bridging vs RT-bridging); 1-year OS was 86.7% in the RT-group, 52.7% in the CT-group and 69% in the no-bridge-group (p = 0.025, CT-bridging vs RT-bridging). We observed a higher incidence of ICANS in patients who received CT than in others (20.0% CT-group, 3.3% RT-group, 7.7% no-bridge group; p = 0.05). In conclusion, RT-bridging is associated with lower drop-out rate and CAR-T toxicity, and it might be preferred to other bridging strategies for patients with localized disease or for those with one prevalent symptomatic site.</p>","PeriodicalId":9126,"journal":{"name":"Bone Marrow Transplantation","volume":" ","pages":""},"PeriodicalIF":4.5,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142387850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Dasatinib maintenance following allogeneic transplantation in acute myeloid leukemia with KIT mutation.","authors":"Dat Ngo, Amanda Blackmon, Monzr M Al Malki","doi":"10.1038/s41409-024-02425-w","DOIUrl":"10.1038/s41409-024-02425-w","url":null,"abstract":"","PeriodicalId":9126,"journal":{"name":"Bone Marrow Transplantation","volume":" ","pages":""},"PeriodicalIF":4.5,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142387848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mohamed Amine Bekadja, Dietger Niederwiser, Mohamed A Kharfan-Dabaja, Riad El Fakih, Laurent Garderet, Ibrahim Yakoub-Agha, Hildegard Greinix, Daniel J Weisdorf, Sebastian Galeano, Syed Osman Ahmed, Christian Chabanon, Shahrukh K Hashmi, Annalisa Ruggeri, Usama Gergis, Ali Bazarbachi, Nada Hamad, Amal Albeihany, Marcelo Pasquini, Amr Hanbali, Jeff Szer, Yoshihisa Kodera, Ambuj Kumar, Tusneem Elhassan, Donal McLornan, Nina Worel, Raffaella Greco, Mohamad Mohty, Yoshiko Atsuta, Mickey Koh, Anna Sureda, Damiano Rondelli, Mahmoud Aljurf, Walid Rasheed
{"title":"Non-cryopreserved autologous peripheral blood stem cell transplantation for multiple myeloma and lymphoma in countries with limited resources: practice considerations from the Worldwide Network for Blood and Marrow Transplantation.","authors":"Mohamed Amine Bekadja, Dietger Niederwiser, Mohamed A Kharfan-Dabaja, Riad El Fakih, Laurent Garderet, Ibrahim Yakoub-Agha, Hildegard Greinix, Daniel J Weisdorf, Sebastian Galeano, Syed Osman Ahmed, Christian Chabanon, Shahrukh K Hashmi, Annalisa Ruggeri, Usama Gergis, Ali Bazarbachi, Nada Hamad, Amal Albeihany, Marcelo Pasquini, Amr Hanbali, Jeff Szer, Yoshihisa Kodera, Ambuj Kumar, Tusneem Elhassan, Donal McLornan, Nina Worel, Raffaella Greco, Mohamad Mohty, Yoshiko Atsuta, Mickey Koh, Anna Sureda, Damiano Rondelli, Mahmoud Aljurf, Walid Rasheed","doi":"10.1038/s41409-024-02431-y","DOIUrl":"https://doi.org/10.1038/s41409-024-02431-y","url":null,"abstract":"<p><p>Autologous peripheral blood stem cell (PBSC) transplantation is a standard treatment of multiple myeloma (MM), Hodgkin lymphoma and various subtypes of non-Hodgkin lymphoma. Cryopreservation of hematopoietic stem cells is standard practice that allows time for delivery of conditioning regimen prior to cell infusion. The aim of this Worldwide Network for Blood & Marrow Transplantation (WBMT) work was to assess existing evidence on non-cryopreserved autologous transplants through a systematic review/meta-analysis, to study feasibility and safety of this approach. We searched PubMed, Web of Science and SCOPUS for studies that utilized non-cryopreserved autologous PBSC transplantation. Identified literature was reviewed for information on mobilization, apheresis, preservation and viability, conditioning regimen, engraftment, response, and survival. Results highlight collective experience from 19 transplant centers (1686 patients), that performed autologous transplants using non-cryopreserved PBSCs. The mean of infused CD34+ was 5.6 × 10<sup>6</sup>/kg. Stem cell viability at transplantation was >90% in MM and >75% in lymphomas, after a storage time of 24-144 h at +4 °C. Mean time-to-neutrophil engraftment was 12 days and 15.3 days for platelets. Pooled proportion estimates of day 100 transplant-related mortality and graft failure were 1% and 0%, respectively. Non-cryopreservation of apheresed autologous PBSCs appears feasible and safe.</p>","PeriodicalId":9126,"journal":{"name":"Bone Marrow Transplantation","volume":" ","pages":""},"PeriodicalIF":4.5,"publicationDate":"2024-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142387849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Marion Larue, Myriam Labopin, Eolia Brissot, Ahmed S Alaskar, Mahmoud Aljurf, Mutlu Arat, Frederic Baron, Ali Bazarbachi, Fabio Ciceri, Selim Corbacioglu, Fiona L Dignan, Michelle Kenyon, Florent Malard, Arnon Nagler, Antonio Pagliuca, Annalisa Ruggeri, Ibrahim Yakoub-Agha, Yishan Ye, Rafael F Duarte, Tapani Ruutu, Enric Carreras, Zinaida Peric, Mohamad Mohty
{"title":"An international survey to better understand the current incidence, severity, and management of VOD/SOS.","authors":"Marion Larue, Myriam Labopin, Eolia Brissot, Ahmed S Alaskar, Mahmoud Aljurf, Mutlu Arat, Frederic Baron, Ali Bazarbachi, Fabio Ciceri, Selim Corbacioglu, Fiona L Dignan, Michelle Kenyon, Florent Malard, Arnon Nagler, Antonio Pagliuca, Annalisa Ruggeri, Ibrahim Yakoub-Agha, Yishan Ye, Rafael F Duarte, Tapani Ruutu, Enric Carreras, Zinaida Peric, Mohamad Mohty","doi":"10.1038/s41409-024-02434-9","DOIUrl":"https://doi.org/10.1038/s41409-024-02434-9","url":null,"abstract":"<p><p>This international questionnaire survey aimed to explore the current incidence, diagnostic policies, management, and outcomes of veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) among healthcare providers involved in the management of these patients. A questionnaire was e-mailed to practitioners with an interest in allogeneic hematopoietic cell transplantation (allo-HCT). Of the respondents, 144 of 215 (67.0%) felt that early detection or diagnosis of VOD/SOS was difficult. Regarding diagnostic criteria, 142 (66.1%) already declared using the 2023 EBMT refined criteria. Most respondents (163/215, 75.8%) found these recent refined EBMT criteria useful for diagnosis, and 193 (89.8%) found the severity criteria easy to use. The major risk factors identified for VOD/SOS were a second allo-HCT (41.4%), pre-existing liver disease (54.9%), and prior use of antibody-drug conjugates (49.8%). Preferences for starting VOD/SOS treatment varied, with 61 (28.4%) preferring initiating therapy at a mild stage, and 122 (56.7%) preferring the moderate stage. In summary, this survey provided valuable insight into the challenges and opportunities of the identification and management of VOD/SOS. By improving current knowledge and increasing collaboration among healthcare professionals, early detection, management, and clinical outcomes for patients with this potentially serious complication can also be improved.</p>","PeriodicalId":9126,"journal":{"name":"Bone Marrow Transplantation","volume":" ","pages":""},"PeriodicalIF":4.5,"publicationDate":"2024-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142387846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"(Donor) age is more than just a number….","authors":"Colin Vale, Amelia A Langston","doi":"10.1038/s41409-024-02420-1","DOIUrl":"https://doi.org/10.1038/s41409-024-02420-1","url":null,"abstract":"","PeriodicalId":9126,"journal":{"name":"Bone Marrow Transplantation","volume":" ","pages":""},"PeriodicalIF":4.5,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142375119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Laila Schneidewind, Thomas Neumann, Nadette Peters, Jennifer Kranz, Kai A Probst, Florian H Heidel, Oliver W Hakenberg, William Krüger
{"title":"Correction: Significance of men's health in long-term survivors of allogeneic stem cell transplantation.","authors":"Laila Schneidewind, Thomas Neumann, Nadette Peters, Jennifer Kranz, Kai A Probst, Florian H Heidel, Oliver W Hakenberg, William Krüger","doi":"10.1038/s41409-024-02415-y","DOIUrl":"https://doi.org/10.1038/s41409-024-02415-y","url":null,"abstract":"","PeriodicalId":9126,"journal":{"name":"Bone Marrow Transplantation","volume":" ","pages":""},"PeriodicalIF":4.5,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142375120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}